Delirium severity does not differ between medical and surgical intensive care units after adjusting for medication use

Damaris Ortiz, Heidi L Lindroth, Tyler Braly, Anthony J Perkins, Sanjay Mohanty, Ashley D Meagher, Sikandar H Khan, Malaz A Boustani, Babar A Khan, Damaris Ortiz, Heidi L Lindroth, Tyler Braly, Anthony J Perkins, Sanjay Mohanty, Ashley D Meagher, Sikandar H Khan, Malaz A Boustani, Babar A Khan

Abstract

Severe delirium is associated with an increased risk of mortality, institutionalization, and length of stay. Few studies have examined differences in delirium severity between different populations of critically ill patients. The objective of the study was to compare delirium severity and the presence of the four core features between adults in the surgical intensive care unit (SICU) and medical intensive care unit (MICU) while controlling for variables known to be associated with delirium. This is a secondary analysis of two parallel randomized multi-center trials conducted from March 2009 to January 2015 at 3 Indianapolis hospitals. A total of 474 adults with delirium were included in the analysis. Subjects were randomized in a 1:1 ratio in random blocks of 4 by a computer program. Patients were randomized to either haloperidol prescribing or de-prescribing regimen vs usual care. Delirium severity was assessed daily or twice-daily using the CAM-ICU-7 beginning after 24 h of ICU admission and until discharge from the hospital, death, or 30 days after enrollment. Secondary outcomes included hospital length of stay, hospital and 30-day mortality, and delirium-related adverse events. These outcomes were compared between SICU and MICU settings for this secondary analysis. Out of 474 patients, 237 were randomized to intervention. At study enrollment, the overall cohort had a mean age of 59 (SD 16) years old, was 54% female, 44% African-American, and 81% were mechanically ventilated upon enrollment. MICU participants were significantly older and severely ill with a higher premorbid cognitive and physical dysfunction burden. In univariate analysis, SICU participants had significantly higher mean total CAM-ICU-7 scores, corresponding to delirium severity, (4.15 (2.20) vs 3.60 (2.32), p = 0.02), and a lower mean RASS score (- 1.79 (1.28) vs - 1.53 (1.27), p < 0.001) compared to MICU participants. Following adjustment for benzodiazepines and opioids, delirium severity did not significantly differ between groups. The presence of Feature 3, altered level of consciousness, was significantly associated with the SICU participants, identifying as Black, premorbid functional impairment, benzodiazepines, opioids, and dexmedetomidine. In this secondary analysis examining differences in delirium severity between MICU and SICU participants, we did not identify a difference between participant populations following adjustment for administered benzodiazepines and opioids. We did identify that an altered level of consciousness, core feature 3 of delirium, was associated with SICU setting, identifying as Black, activities of daily living, benzodiazepines and opioid medications. These results suggest that sedation practice patterns play a bigger role in delirium severity than the underlying physiologic insult, and expression of core features of delirium may vary based on individual factors.Trial registration CT#: NCT00842608.

Conflict of interest statement

The authors declare no competing interests.

© 2022. The Author(s).

Figures

Figure 1
Figure 1
Study participants. PICU, Progressive Intermediate Care Unit; PMD, pharmacological management of delirium; de-PMD, de-prescribing in the pharmacological management of delirium.

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders:DSM-5 (2013).
    1. Vasilevskis EE, Han JH, Hughes CG, Ely EW. Epidemiology and risk factors for delirium across hospital settings. Best Pract. Res. Clin. Anaesthesiol. 2014;26(3):277–287. doi: 10.1016/j.bpa.2012.07.003.
    1. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU) JAMA. 2001;286(21):2703–2710. doi: 10.1001/jama.286.21.2703.
    1. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007;33(1):66–73. doi: 10.1007/s00134-006-0399-8.
    1. Lin SM, Liu CY, Lee KY, et al. The impact of delirium on the survival of mechanically ventilated patients. Crit. Care Med. 2004;32(11):2254–2259. doi: 10.1097/.
    1. Salluh JI, Wang H, Schneider EB, et al. Outcome of delirium in critically ill patients: Systematic review and meta-analysis. BMJ. 2015;350:h2538. doi: 10.1136/bmj.h2538.
    1. Khan BA, Zawahiri M, Campbell NL, et al. Delirium in hospitalized patients: Implications of current evidence on clinical practice and future avenues for research—A systematic evidence review. J. Hosp. Med. 2012;7(7):580–589. doi: 10.1002/jhm.1949.
    1. Kang J, Lee M, Ko H, et al. Effect of nonpharmacological interventions for the prevention of delirium in the intensive care unit: A systematic review and meta-analysis. J. Crit. Care. 2018;48(1):372–384. doi: 10.1016/j.jcrc.2018.09.032.
    1. Kotfis K, Marra A, Ely EW. ICU delirium—A diagnostic and therapeutic challenge in the intensive care unit. Anaesthesiol. Intensive Ther. 2018;50(2):160–167. doi: 10.5603/AIT.a2018.0011.
    1. O’Keeffe ST, Lavan JN. Clinical significance of delirium subtypes in older people. Age Ageing. 1999;28(2):115–119. doi: 10.1093/ageing/28.2.115.
    1. Pun BT, Ely EW. The importance of diagnosing and managing ICU delirium. Chest. 2007;132(1):624–636. doi: 10.1378/chest.06-1795.
    1. Khan BA, Perkins AJ, Campbell NL, et al. Pharmacological management of delirium in the intensive care unit: A randomized pragmatic clinical trial. J. Am. Geriatr. Soc. 2019;67(5):1057–1065. doi: 10.1111/jgs.15781.
    1. Rosgen BK, Krewulak KD, Stelfox HT, Ely EW, Davidson JE, Fiest KM. The association of delirium severity with patient and health system outcomes in hospitalised patients: A systematic review. Age Ageing. 2020;49(4):549–557. doi: 10.1093/ageing/afaa053.
    1. Pisani MA, Murphy TE, Araujo KLB, Van Ness PH. Duration of ICU delirium, severity of underlying disease, and mortality. Am. J. Respir. Crit. Care Med. 2010;181(4):420–421. doi: 10.1164/ajrccm.181.4.420.
    1. Burry L, Hutton B, Williamson DR, et al. Pharmacological interventions for the treatment of delirium in critically ill adults. Cochrane Database Syst. Rev. 2019;9(9):CD011749. doi: 10.1002/14651858.CD011749.pub2.
    1. Vasilevskis EE, Chandrasekhar R, Holtze CH, et al. The cost of ICU delirium and coma in the intensive care unit patient. Med Care. 2018;56(10):890–897. doi: 10.1097/MLR.000000000000975.
    1. van den Boogaard M, Slooter AJC, Bruggemann RJM, et al. Effect of haloperidol on survival among critically ill adults with a high risk of delirium: The REDUCE randomized clinical trial. JAMA. 2018;319(7):680–690. doi: 10.1001/jama.2018.0160.
    1. Kim MS, Rhim HC, Park A, et al. Comparative efficacy and acceptability of pharmacological interventions for the treatment and prevention of delirium: A systematic review and network meta-analysis. J. Psychiatr. Res. 2020;125:164–176. doi: 10.1016/j.jpsychires.2020.03.012.
    1. Tao R, Wang XW, Pang LJ, et al. Pharmacologic prevention of postoperative delirium after on-pump cardiac surgery: A meta-analysis of randomized trials. Medicine. 2018;97(43):e12771. doi: 10.1097/MD.0000000000012771.
    1. Liu X, Xie G, Zhang K, et al. Dexmedetomidine vs propofol sedation reduces delirium in patients after cardiac surgery: A meta-analysis with trial sequential analysis of randomized controlled trials. J. Crit. Care. 2017;38:190–196. doi: 10.1016/j.jcrc.2016.10.026.
    1. Wu M, Liang Y, Dai Z, Wang S. Perioperative dexmedetomidine reduces delirium after cardiac surgery: A meta-analysis of randomized controlled trials. J. Clin. Anesth. 2018;50:33–42. doi: 10.1016/j.jclinane.2018.06.045.
    1. Su X, Meng ZT, Wu XH, et al. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: A randomised, double-blind, placebo-controlled trial. Lancet. 2016;388(10054):1893–1902. doi: 10.1016/S0140-6736(16)30580-3.
    1. Janssen TL, Alberts AR, Hooft L, et al. Prevention of postoperative delirium in elderly patients planned for elective surgery: Systematic review and meta-analysis. Clin. Interv. Aging. 2019;19(14):1095–1117. doi: 10.2147/CIA.S201323.eCollection2019.
    1. Khan BA, Perkins AJ, Campbell JL, et al. Preventing postoperative delirium after major noncardiac thoracic surgery—A randomized clinical trial. J. Am. Geriatr. Soc. 2018;66(12):2289–2297. doi: 10.1111/jgs.15640.
    1. Deiner S, Luo X, Lin HM, et al. Intraoperative infusion of dexmedetomidine for prevention of postoperative delirium and cognitive dysfunction in elderly patients undergoing major elective noncardiac surgery: A randomized clinical trial. JAMA Surg. 2017;152(8):3171505. doi: 10.1001/jamasurg.2017.1505.
    1. Bigatello LM, Amirfarzan J, Haghighi AK, et al. Effects of routine monitoring of delirium in a surgical/trauma intensive care unit. J. Trauma Acute Care Surg. 2013;74(3):876–883. doi: 10.1097/TA.0b013e31827e1b69.
    1. Pandharipande P, Cotton BA, Shintani A, et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J. Trauma. 2008;65(1):34–41. doi: 10.1097/TA.0b013e31814b2c4d.
    1. Campbell NL, Perkins AJ, Khan BA, et al. Deprescribing in the pharmacologic management of delirium: A randomized trial in the intensive care unit. J. Am. Geriatr. Soc. 2019;67(4):695–702. doi: 10.1111/jgs.15751.
    1. Campbell NL, Khan AB, Farber M, et al. Improving delirium care in the intensive care unit: The design of a pragmatic study. Trials. 2011 doi: 10.1186/1745-6215-12-139.
    1. Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: Validation of the Confusion Assesment Method for the Intensive Care Unit (CAM-ICU) Crit. Care Med. 2001;29(7):1370–1379. doi: 10.1097/00003246-200107000-00012.
    1. Reddy DRS, Singh TD, Guru PK, et al. Identification of acute brain failure using electronic medical records. J. Crit. Care. 2016;34(1):12–16. doi: 10.1016/j.jcrc.2016.03.008.
    1. Jorm AF. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): A review. Int. Psychogeriatr. 2004;16(3):275–293. doi: 10.1017/S1041610204000390.
    1. Graf C. The Lawton instrumental activities of daily living (iADL) scale. Am. J. Nurs. 2008;108(4):52–63. doi: 10.1097/01.NAJ.0000314810.46029.74.
    1. Katz P. Measures of adult general functional status. The Barthel index, Katz index of activities of daily living, Health Assessment Questionnaire (HAQ), MACTAR Patient Preference Disability questionnaire, and Modified Health Assessment Questionnaire (MHAQ) Arthr. Rheum. (Arthr. Care Res.) 2003;49(5S):S15–S27.
    1. Khan BA, Perkins AJ, Gao S, et al. The CAM-ICU-7 delirium severity scale: A novel delirium severity instrument for use in the intensive care unit. Crit. Care Med. 2017;45(5):851–857. doi: 10.1097/CCM.0000000000002368.
    1. Matsuishi Y, Shimojo N, Unoki T, et al. Type D personality is a predictor of prolonged acute brain dysfunction (delirium/coma) after cardiovascular surgery. BMC Psychol. 2019 doi: 10.1186/s40359-019-0303-2.
    1. Vasilevskis EE, Chandrasekhar R, Holtze CH, et al. The cost of ICU delirium and coma in the intensive care unit patient. Med. Care. 2018;56(10):890–897. doi: 10.1097/MLR.0000000000000975.
    1. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit. Care Med. 2013;41(1):263–306. doi: 10.1097/CCM.0b013e3182783b72.
    1. Andrews PS, Wang S, Perkins AJ, et al. Relationship between intensive care unit delirium severity and 2-year mortality and health care utilization. Am. J. Crit. Care. 2020;29(4):311–317. doi: 10.4037/ajcc2020498.
    1. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA. 1996;275(11):852–857. doi: 10.1001/jama.1996.03530350034031.
    1. Sanders RD. Hypothesis for the pathophysiology of delirium: Role of baseline brain network connectivity and changes in inhibitory tone. Med. Hypotheses. 2011;77(1):140–143. doi: 10.1016/j.mehy.2011.03.048.
    1. Ahmed S, Leurent B, Sampson EL. Risk factors for incident delirium among older people in acute hospital medical units: A systematic review and meta-analysis. Age Ageing. 2014;43(3):326–333. doi: 10.1093/ageing/afu022.
    1. Zaal IJ, Devlin JW, Peelen LM, Slooter AJ. A systematic review of risk factors for delirium in the ICU. Crit. Care Med. 2015;43(1):40–47. doi: 10.1097/CCM.000000000000625.
    1. Marcantonio ER. Delirium in hospitalized older adults. N. Engl. J. Med. 2017;377:1456–1466. doi: 10.1056/NEJMcp1605501.
    1. Chan MT, Cheng BC, Lee TM, Gin T, CODA Trial Group BIS-guided anesthesia decreases postoperative delirium and cognitive decline. J. Neurosurg. Anesthesiol. 2013;25(1):33–42. doi: 10.1097/ANA.0b013e3182712fba.
    1. Evered LA, Chan MTV, Han R, et al. Anaesthetic depth and delirium after major surgery: A randomised clinical trial. Br. J. Anaesth. 2021;127:704–712. doi: 10.1016/j.bja.2021.07.021.
    1. Lindroth H, et al. Delirium severity trajectories and outcomes in ICU patients: Defining a dynamic symptom phenotype. Ann. Am. Thorac. Soc. 2020 doi: 10.1513/AnnalsATS.201910-764OC.
    1. Khan BA, Perkins A, Hui SL, et al. Relationship between African-American race and delirium in the ICU. Crit. Care Med. 2016;44(9):1727–1734. doi: 10.1097/CCM.0000000000001813.
    1. Ortolani O, Conti A, Chan YK, Sie MY, Ong GS. Comparison of propofol consumption and recovery time in Caucasians from Italy, with Chinese, Malays and Indians from Malaysia. Anaesth. Intensive Care. 2004;32(2):250–255. doi: 10.1177/0310057X0403200215.
    1. Oreste O, Conti A, Sall-Ka B, et al. The recovery of Senegalese African Blacks from intravenous anesthesia with propofol and remifentanil is slower than that of Caucasians. Anesth. Analg. 2001;93(5):1222–12226. doi: 10.1097/00000539-200111000-00036.
    1. Cepeda MS, Farrar JT, Roa JH, et al. Ethnicity influences morphine pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther. 2001;70(4):351–361. doi: 10.1016/S0009-9236(01)45600-1.
    1. Wu WD, Wang Y, Fang YM, Zhou HY. Polymorphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during anesthesia and recovery. Mol. Diagn. Ther. 2009;13(5):331–337. doi: 10.1007/BF03256337.
    1. Lampotang S, Lizdas DE, Derendorf H, et al. Race-specific pharmacodynamic model of propofol-induced loss of consciousness. J. Clin. Pharm. 2016;56(9):1141–1150. doi: 10.1002/jcph.716.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever